These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 8504628)

  • 1. Rapid and selective inhibition of platelet aggregation and thromboxane formation by intravenous low dose aspirin in man.
    Böger RH; Bode-Böger SM; Gutzki FM; Tsikas D; Weskott HP; Frölich JC
    Clin Sci (Lond); 1993 May; 84(5):517-24. PubMed ID: 8504628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of very low dose and enteric-coated acetylsalicylic acid on prostacyclin and thromboxane formation and on bleeding time in healthy subjects.
    Bode-Böger SM; Böger RH; Schubert M; Frölich JC
    Eur J Clin Pharmacol; 1998; 54(9-10):707-14. PubMed ID: 9923572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continued thromboxane A2 formation despite administration of a platelet glycoprotein IIb/IIIa antagonist in patients undergoing coronary angioplasty.
    Byrne A; Moran N; Maher M; Walsh N; Crean P; Fitzgerald DJ
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3224-9. PubMed ID: 9409315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin.
    Clarke RJ; Mayo G; Price P; FitzGerald GA
    N Engl J Med; 1991 Oct; 325(16):1137-41. PubMed ID: 1891022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of two preparations of 75-mg extended-release aspirin on platelet aggregation, prostanoids and nitric oxide production in humans.
    de la Cruz JP; Guerrero A; González-Correa JA; Márquez E; Nacle I; Sánchez de la Cuesta F
    Eur J Clin Pharmacol; 2002 Jan; 57(11):775-80. PubMed ID: 11871383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of salicylic and acetylsalicylic acid alone and in combination on platelet aggregation and prostanoid synthesis in man.
    Rosenkranz B; Fischer C; Meese CO; Frölich JC
    Br J Clin Pharmacol; 1986 Mar; 21(3):309-17. PubMed ID: 3083851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet function and biosynthesis of prostacyclin and thromboxane A2 in whole blood after aspirin administration in human subjects.
    Mehta JL; Mehta P; Lopez L; Ostrowski N; Aguila E
    J Am Coll Cardiol; 1984 Oct; 4(4):806-11. PubMed ID: 6384329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin.
    Preston FE; Whipps S; Jackson CA; French AJ; Wyld PJ; Stoddard CJ
    N Engl J Med; 1981 Jan; 304(2):76-9. PubMed ID: 7003384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential inhibition by low-dose aspirin of human venous prostacyclin synthesis and platelet thromboxane synthesis.
    Hanley SP; Bevan J; Cockbill SR; Heptinstall S
    Lancet; 1981 May; 1(8227):969-71. PubMed ID: 6112387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective and nonselective inhibition of thromboxane formation.
    FitzGerald GA; Oates JA
    Clin Pharmacol Ther; 1984 May; 35(5):633-40. PubMed ID: 6370554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of enteric-coated, low-dose aspirin on parameters of platelet function.
    Van Hecken A; Juliano ML; Depré M; De Lepeleire I; Arnout J; Dynder A; Wildonger L; Petty KJ; Gottesdiener K; De Hoon JN
    Aliment Pharmacol Ther; 2002 Sep; 16(9):1683-8. PubMed ID: 12197849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebo-controlled trial of regular and enteric coated formulations in men and women.
    Ridker PM; Hennekens CH; Tofler GH; Lipinska I; Buring JE
    J Cardiovasc Risk; 1996 Apr; 3(2):209-12. PubMed ID: 8836865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential inhibition of human platelet aggregation and thromboxane A2 formation by L-arginine in vivo and in vitro.
    Bode-Böger SM; Böger RH; Galland A; Frölich JC
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Feb; 357(2):143-50. PubMed ID: 9521487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.
    FitzGerald GA; Oates JA; Hawiger J; Maas RL; Roberts LJ; Lawson JA; Brash AR
    J Clin Invest; 1983 Mar; 71(3):676-88. PubMed ID: 6338043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 24-hour time-dependent aspirin efficacy in patients with stable coronary artery disease.
    Henry P; Vermillet A; Boval B; Guyetand C; Petroni T; Dillinger JG; Sideris G; Bal dit Sollier C; Drouet L
    Thromb Haemost; 2011 Feb; 105(2):336-44. PubMed ID: 21136023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction.
    Fitzgerald DJ; Catella F; Roy L; FitzGerald GA
    Circulation; 1988 Jan; 77(1):142-50. PubMed ID: 3275505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of alternate-day regular and enteric-coated aspirin on platelet aggregation, bleeding time, and thromboxane A2 levels in bleeding-time blood.
    Stampfer MJ; Jakubowski JA; Deykin D; Schafer AI; Willett WC; Hennekens CH
    Am J Med; 1986 Sep; 81(3):400-4. PubMed ID: 3529953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ridogrel inhibits systemic and renal formation of thromboxane A2 and antagonizes platelet thromboxane A2/prostaglandin endoperoxide receptors upon chronic administration to man.
    Weber C; Beetens JR; Tegtmeier F; Van Rooy P; Vercammen E; Wouters L; De Clerck F
    Thromb Haemost; 1992 Aug; 68(2):214-20. PubMed ID: 1412169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential inhibition by aspirin of vascular and platelet prostaglandin synthesis in atherosclerotic patients.
    Weksler BB; Pett SB; Alonso D; Richter RC; Stelzer P; Subramanian V; Tack-Goldman K; Gay WA
    N Engl J Med; 1983 Apr; 308(14):800-5. PubMed ID: 6339916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of low-dose aspirin on in vitro platelet aggregation in the early minutes after ingestion in normal subjects.
    Dabaghi SF; Kamat SG; Payne J; Marks GF; Roberts R; Schafer AI; Kleiman NS
    Am J Cardiol; 1994 Oct; 74(7):720-3. PubMed ID: 7942533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.